Evidence map›Paper›PMID 16951346›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2006

Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

David M Cauvi, Gabrielle Cauvi, K Michael Pollard

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David M CauviDepartment of Molecular and Experimental Medicine, W. M. Keck Autoimmune Disease Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Gabrielle Cauvi
K Michael Pollard
Scripps Research Institute · US

Funding

MERCURY INDUCED AUTOIMMUNITYR01ES007511 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI POLLARD, KENNETH MICHAEL · 1997 to 2007
$2.1M
IMMUNOTOXICOLOGY OF A HEAVY METALR01ES008080 · NIEHS · SCRIPPS RESEARCH INSTITUTE · PI POLLARD, KENNETH MICHAEL · 1996 to 2004
$1.3M
XENOBIOTIC ACCELERATION OF AUTOIMMUNITYR01ES009802 · NIEHS · SCRIPPS RESEARCH INSTITUTE · PI POLLARD, KENNETH MICHAEL · 2000 to 2003
$1.2M
NIEHS NIH HHS ES07511NIEHS NIH HHS ES08080NIEHS NIH HHS ES09802NIEHS NIH HHS R01 ES007511NIEHS NIH HHS R01 ES008080NIEHS NIH HHS R01 ES009802
6 · The paper itself

Abstract

The complement regulatory protein decay-accelerating factor (DAF or CD55) protects host tissue from complement-mediated injury by inhibiting the classical and alternative complement pathways. Besides its role in complement regulation, DAF has also been shown to be a key player in T cell immunity. Modulation of DAF expression could therefore represent a critical regulatory mechanism in both innate and adaptive immune responses. To identify and characterize key transcriptional regulatory elements controlling mouse Daf1 expression, a 2.5-kb fragment corresponding to the 5' flanking region of the mouse Daf1 gene was cloned. Sequence analysis showed that the mouse Daf1 promoter lacks conventional TATA and CCAAT boxes and displays a high guanine and cytosine content. RACE was used to identify one major and two minor transcription start sites 47, 20, and 17 bp upstream of the translational codon. Positive and negative regulatory regions were identified by transiently transfecting sequential 5'deletion constructs of the 5'flanking region into NIH/3T3, M12.4, and RAW264.7 cells. Mutational analyses of the promoter region combined with Sp1-specific ELISA showed that the transcription factor Sp1 is required for basal transcription and LPS-induced expression of the Daf1 gene. These findings provide new information on the regulation of the mouse Daf1 promoter and will facilitate further studies on the expression of Daf1 during immune responses.

Indexed as

5' Flanking RegionAnimalsBase SequenceB-LymphocytesCD55 AntigensGene Expression RegulationHumansLipopolysaccharidesMiceMice, Inbred DBAMolecular Sequence DataNIH 3T3 CellsSp1 Transcription FactorCD55 AntigensLipopolysaccharidesSp1 Transcription Factor

Identifiers

PMID16951346
PMCPMC1766464
OpenAlexW2129180560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.